🇮🇪·19h agoIndustry
Perrigo to Release Second Quarter 2026 Financial Results on August 5, 2026
Publisher
P
Perrigo (IR)
Ireland
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Perrigo (IR)
- Region
- Ireland
- Scope
- Industry
- Published
- July 22, 2026
- Language
- EN
Topics
otcpharma
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on investor.perrigo.com
Leave the platform to read the original full article on the publisher site.
Source: Perrigo (IR)
Scope: Industry
Related coverage
More related coverage
Roche News RSS/3h ago
More details
Nippon Shinyaku News/4h ago
NS-025の全世界における開発・製造・販売に関する独占的ライセンス契約締結のお知らせ
Royalty Pharma/8h ago
Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune
NEW YORK, NY, July 22, 2026 — Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired...
Nippon Shinyaku News/8h ago